posted on 2022-01-21, 14:03authored byMasaki Watanabe, Mariko Nakamura-Nakayama, Michiko Fujihara, Mayu Kawasaki, Shogo Nakano, Hiroki Kakuta
Screening
for small-molecule modulators targeting a particular
receptor is frequently based on measurement of Kd, i.e., the binding constant between the receptor and the
compound of interest. However, Kd values
also reflect binding at receptor protein sites other than the modulatory
site. We designed derivatives of retinoid X receptor (RXR) antagonist
CBTF-EE (1) with modifications that altered their conformational
flexibility. Compounds 6a,b and 7a,b showed quite similar Kd values, but 7a,b exhibited 10-fold higher Ki values than those of 6a,b. Further, 6a,b showed potent RXR-antagonistic
activity, while 7a,b were inactive. These
results suggest that increased conformational flexibility promotes
binding at nontarget receptor sites. In this situation, conventional
determination of Kd is less effective
for screening purposes than the determination of Ki using a ligand that binds specifically to the site regulating
transcriptional activity. Thus, the use of Ki values for orthosteric ligands may increase the hit rate
in screening active regulatory molecules.